Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases

References

• Freeman MW, Arrott A, Watson JHL. (1960). Magnetism in medicine. J Appl Phys 31:1–15. doi: 10.1063/1.1984765.
   Web of Science ®Google Scholar
• Lubbe AS, Bergemann C, Riess H, et al. (1996). Clinical experiences with magnetic drug targeting: a phase I study with 4’-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56:4686–93.
   PubMed Web of Science ®Google Scholar
• Alexiou C, Arnold W, Klein RJ, et al. (2000). Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60:6641–8.
   PubMed Web of Science ®Google Scholar
• Vandergriff AC, Hensley TM, Henry ET, et al. (2014). Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. Biomaterials 35:8528–39. doi: 10.1016/j.biomaterials.2014.06.031.
   PubMed Web of Science ®Google Scholar
• Schwerdt JI, Goya GF, Calatayud MP, et al. (2012). Magnetic field-assisted gene delivery: achievements and therapeutic potential. Curr Gene Ther 12:116–26.
   PubMed Web of Science ®Google Scholar
• Liu S, Chen X, Bao L, et al. (2020). Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nat Biomed Eng 4:1063–75. doi: 10.1038/s41551-020-00637-1.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen S, Zhu Y, et al. (2018). Triple-modal imaging-guided chemo-photothermal synergistic therapy for breast cancer with magnetically targeted phase-shifted nanoparticles. ACS Appl Mater Interfaces 10:42102–14. doi: 10.1021/acsami.8b16323.
   PubMed Web of Science ®Google Scholar
• Li M, Bu W, Ren J, et al. (2018). Enhanced synergism of thermo-chemotherapy for liver cancer with magnetothermally responsive nanocarriers. Theranostics 8:693–709. doi: 10.7150/thno.21297.
   PubMed Web of Science ®Google Scholar
• Li WP, Liao PY, Su CH, Yeh CS. (2014). Formation of oligonucleotide-gated silica shell-coated Fe(3)O(4)-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform. J Am Chem Soc 136:10062–75. doi: 10.1021/ja504118q.
   PubMed Web of Science ®Google Scholar
• Liu YL, Chen D, Shang P, Yin DC. (2019). A review of magnet systems for targeted drug delivery. J Control Release 302:90–104. doi: 10.1016/j.jconrel.2019.03.031.
   PubMed Web of Science ®Google Scholar
• Bietenbeck M, Florian A, Faber C, et al. (2016). Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now? Int J Nanomedicine 11:3191–203. doi: 10.2147/IJN.S110542.
   PubMed Web of Science ®Google Scholar
• Riegler J, Lau KD, Garcia-Prieto A, et al. (2011). Magnetic cell delivery for peripheral arterial disease: a theoretical framework. Med Phys 38:3932–43. doi: 10.1118/1.3593363.
   PubMed Web of Science ®Google Scholar
• Shen WB, Anastasiadis P, Nguyen B, et al. (2017). Magnetic enhancement of stem cell-targeted delivery into the brain following mr-guided focused ultrasound for opening the blood-brain barrier. Cell Transplant 26:1235–46. doi: 10.1177/0963689717715824.
   PubMed Web of Science ®Google Scholar
• Voronin DV, Sindeeva OA, Kurochkin MA, et al. (2017). In vitro and in vivo visualization and trapping of fluorescent magnetic microcapsules in a bloodstream. ACS Appl Mater Interfaces 9:6885–93. doi: 10.1021/acsami.6b15811.
   PubMed Web of Science ®Google Scholar
• Shapiro B, Dormer K, Rutel IB. (2010). A two-magnet system to push therapeutic nanoparticles. AIP Conf Proc 1311:77–88.
   PubMedGoogle Scholar
• Liu JF, Lan Z, Ferrari C, et al. (2020). Use of oppositely polarized external magnets to improve the accumulation and penetration of magnetic nanocarriers into solid tumors. ACS Nano 14:142–52. doi: 10.1021/acsnano.9b05660.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Shen Z, Chen X. (2020). Tale of two magnets: an advanced magnetic targeting system. ACS Nano 14:7–11. doi: 10.1021/acsnano.9b06842.
   PubMed Web of Science ®Google Scholar
• Roeth AA, Slabu I, Baumann M, et al. (2017). Establishment of a biophysical model to optimize endoscopic targeting of magnetic nanoparticles for cancer treatment. Int J Nanomedicine 12:5933–40. doi: 10.2147/IJN.S132162.
   PubMed Web of Science ®Google Scholar
• Riegler J, Wells JA, Kyrtatos PG, et al. (2010). Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 31:5366–71. doi: 10.1016/j.biomaterials.2010.03.032.
   PubMed Web of Science ®Google Scholar
• Vartholomeos P, Fruchard M, Ferreira A, Mavroidis C. (2011). MRI-guided nanorobotic systems for therapeutic and diagnostic applications. Annu Rev Biomed Eng 13:157–84. doi: 10.1146/annurev-bioeng-071910-124724.
   PubMed Web of Science ®Google Scholar
• Muthana M, Kennerley AJ, Hughes R, et al. (2015). Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nat Commun 6:8009. doi: 10.1038/ncomms9009.
   PubMed Web of Science ®Google Scholar
• Polyak B, Friedman G. (2009). Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin Drug Deliv 6:53–70. doi: 10.1517/17425240802662795.
   PubMed Web of Science ®Google Scholar
• McNab JA, Edlow BL, Witzel T, et al. (2013). The human connectome project and beyond: initial applications of 300 mT/m gradients. Neuroimage 80:234–45. doi: 10.1016/j.neuroimage.2013.05.074.
   PubMed Web of Science ®Google Scholar
• Baker RR, Payne C, Yu Y, et al. (2022). Image-guided magnetic thermoseed navigation and tumor ablation using a magnetic resonance imaging system. Adv Sci 9:e2105333.
   Web of Science ®Google Scholar
• Shen Y, Liu X, Huang Z, et al. (2015). Comparison of magnetic intensities for mesenchymal stem cell targeting therapy on ischemic myocardial repair: high magnetic intensity improves cell retention but has no additional functional benefit. Cell Transplant 24:1981–97. doi: 10.3727/096368914X685302.
   PubMed Web of Science ®Google Scholar
• Liu X, Yan B, Li Y, et al. (2020). Graphene oxide-grafted magnetic nanorings mediated magnetothermodynamic therapy favoring reactive oxygen species-related immune response for enhanced antitumor efficacy. ACS Nano 14:1936–50. doi: 10.1021/acsnano.9b08320.
   PubMed Web of Science ®Google Scholar
• Nana ABA, Marimuthu T, Kondiah PPD, et al. (2019). Multifunctional magnetic nanowires: design, fabrication, and future prospects as cancer therapeutics. Cancers 11:1956. doi: 10.3390/cancers11121956.
   PubMed Web of Science ®Google Scholar
• Son SJ, Reichel J, He B, et al. (2005). Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery. J Am Chem Soc 127:7316–7. doi: 10.1021/ja0517365.
   PubMed Web of Science ®Google Scholar
• Jiang K, Zhang L, Bao G. (2021). Magnetic iron oxide nanoparticles for biomedical applications. Curr Opin Biomed Eng 20:100330. doi: 10.1016/j.cobme.2021.100330.
   PubMedGoogle Scholar
• Cheng K, Shen D, Hensley MT, et al. (2014). Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. Nat Commun 5:4880. doi: 10.1038/ncomms5880.
   PubMed Web of Science ®Google Scholar
• Veloso SRS, Andrade RGD, Castanheira EMS. (2021). Magnetoliposomes: recent advances in the field of controlled drug delivery. Expert Opin Drug Deliv 18:1323–34. doi: 10.1080/17425247.2021.1915983.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48. doi: 10.1016/j.addr.2012.09.037.
   PubMed Web of Science ®Google Scholar
• Chertok B, Langer R. (2018). Circulating magnetic microbubbles for localized real-time control of drug delivery by ultrasonography-guided magnetic targeting and ultrasound. Theranostics 8:341–57. doi: 10.7150/thno.20781.
   PubMed Web of Science ®Google Scholar
• Zhou H, Mayorga-Martinez CC, Pane S, et al. (2021). Magnetically driven micro and nanorobots. Chem Rev 121:4999–5041. doi: 10.1021/acs.chemrev.0c01234.
   PubMed Web of Science ®Google Scholar
• Chesnitskiy AV, Gayduk AE, Seleznev VA, Prinz VY. (2022). Bio-inspired micro- and nanorobotics driven by magnetic field. Materials 15:7781. doi: 10.3390/ma15217781.
   PubMed Web of Science ®Google Scholar
• Villa K, Pumera M. (2019). Fuel-free light-driven micro/nanomachines: artificial active matter mimicking nature. Chem Soc Rev 48:4966–78. doi: 10.1039/c9cs00090a.
   PubMed Web of Science ®Google Scholar
• Aghakhani A, Yasa O, Wrede P, Sitti M. (2020). Acoustically powered surface-slipping mobile microrobots. Proc Natl Acad Sci U S A 117:3469–77. doi: 10.1073/pnas.1920099117.
   PubMed Web of Science ®Google Scholar
• Field RD, Anandakumaran PN, Sia SK. (2019). Soft medical microrobots: design components and system integration. Appl Phys Rev 6:041305. doi: 10.1063/1.5124007.
   Web of Science ®Google Scholar
• Kobayashi K, Yoon C, Oh SH, et al. (2019). Biodegradable Thermomagnetically Responsive Soft Untethered Grippers. ACS Appl Mater Interfaces 11:151–9. doi: 10.1021/acsami.8b15646.
   PubMed Web of Science ®Google Scholar
• Gong D, Celi N, Zhang D, Cai J. (2022). Magnetic biohybrid microrobot multimers based on chlorella cells for enhanced targeted drug delivery. ACS Appl Mater Interfaces 14:6320–30. doi: 10.1021/acsami.1c16859.
   PubMed Web of Science ®Google Scholar
• Li M, Wu J, Lin D, et al. (2022). A diatom-based biohybrid microrobot with a high drug-loading capacity and pH-sensitive drug release for target therapy. Acta Biomater 154:443–53. doi: 10.1016/j.actbio.2022.10.019.
   PubMed Web of Science ®Google Scholar
• Hines L, Petersen K, Lum GZ, Sitti M. (2017). Soft actuators for small-scale robotics. Adv Mater 29:1603483. doi: 10.1002/adma.201603483.
   Web of Science ®Google Scholar
• Sun J, Zhang L, Wang J, et al. (2015). Tunable rigidity of (polymeric core)-(lipid shell) nanoparticles for regulated cellular uptake. Adv Mater 27:1402–7. doi: 10.1002/adma.201404788.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Song Y, Cao Z, et al. (2023). A magnetically driven amoeba-like nanorobot for whole-process active drug transport. Adv Sci 10:e2204793.
   Web of Science ®Google Scholar
• Hou K, Zhang Y, Bao M, et al. (2022). A multifunctional magnetic red blood cell-mimetic micromotor for drug delivery and image-guided therapy. ACS Appl Mater Interfaces 14:3825–37. doi: 10.1021/acsami.1c21331.
   PubMed Web of Science ®Google Scholar
• Disharoon D, Trewyn BG, Herson PS, et al. (2022). Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen. J Thromb Haemost 20:486–97. doi: 10.1111/jth.15617.
   PubMed Web of Science ®Google Scholar
• Tasci TO, Disharoon D, Schoeman RM, et al. (2017). Enhanced fibrinolysis with magnetically powered colloidal microwheels. Small 13:1700954. doi: 10.1002/smll.201700954.
   Web of Science ®Google Scholar
• Nacev A, Beni C, Bruno O, Shapiro B. (2011). The behaviors of ferro-magnetic nano-particles in and around blood vessels under applied magnetic fields. J Magn Magn Mater 323:651–68. doi: 10.1016/j.jmmm.2010.09.008.
   PubMed Web of Science ®Google Scholar
• Hewlin RLJr., Tindall JM. (2023). Computational assessment of magnetic nanoparticle targeting efficiency in a simplified circle of willis arterial model. Int J Mol Sci 24:2545. doi: 10.3390/ijms24032545.
   PubMed Web of Science ®Google Scholar
• Sodagar H, Shakiba A, Niazmand H. (2020). Numerical investigation of drug delivery by using magnetic field in a 90-degree bent vessel: a 3D simulation. Biomech Model Mechanobiol 19:2255–69. doi: 10.1007/s10237-020-01337-0.
   PubMed Web of Science ®Google Scholar
• Manshadi MKD, Saadat M, Mohammadi M, et al. (2018). Delivery of magnetic micro/nanoparticles and magnetic-based drug/cargo into arterial flow for targeted therapy. Drug Deliv 25:1963–73. doi: 10.1080/10717544.2018.1497106.
   PubMed Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003. doi: 10.1038/nmat3776.
   PubMed Web of Science ®Google Scholar
• Amstad E, Kohlbrecher J, Muller E, et al. (2011). Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Lett 11:1664–70. doi: 10.1021/nl2001499.
   PubMed Web of Science ®Google Scholar
• Nitica S, Fizesan I, Dudric R, et al. (2022). Doxorubicin loaded thermosensitive magneto-liposomes obtained by a gel hydration technique: characterization and in vitro magneto-chemotherapeutic effect assessment. Pharmaceutics 14:2501. doi: 10.3390/pharmaceutics14112501.
   PubMed Web of Science ®Google Scholar
• Beguin E, Gray MD, Logan KA, et al. (2020). Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device. J Control Release 317:23–33. doi: 10.1016/j.jconrel.2019.11.013.
   PubMed Web of Science ®Google Scholar
• Park J, Kim JY, Pane S, et al. (2021). Acoustically mediated controlled drug release and targeted therapy with degradable 3D porous magnetic microrobots. Adv Healthc Mater 10:e2001096.
   PubMed Web of Science ®Google Scholar
• Xing Y, Zeng B, Yang W. (2022). Light responsive hydrogels for controlled drug delivery. Front Bioeng Biotechnol 10:1075670. doi: 10.3389/fbioe.2022.1075670.
   PubMed Web of Science ®Google Scholar
• Song X, Chen Z, Zhang X, et al. (2021). Magnetic tri-bead microrobot assisted near-infrared triggered combined photothermal and chemotherapy of cancer cells. Sci Rep 11:7907. doi: 10.1038/s41598-021-87010-7.
   PubMed Web of Science ®Google Scholar
• Wang B, Qin Y, Liu J, et al. (2023). Magnetotactic Bacteria-Based Drug-Loaded Micromotors for Highly Efficient Magnetic and Biological Double-Targeted Tumor Therapy. ACS Appl Mater Interfaces 15:2747–59. doi: 10.1021/acsami.2c19960.
   PubMed Web of Science ®Google Scholar
• Feng Q, Zhang Y, Zhang W, et al. (2017). Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy. Acta Biomater 49:402–13. doi: 10.1016/j.actbio.2016.11.035.
   PubMed Web of Science ®Google Scholar
• Servant A, Methven L, Williams RP, Kostarelos K. (2013). Electroresponsive polymer-carbon nanotube hydrogel hybrids for pulsatile drug delivery in vivo. Adv Healthc Mater 2:806–11. doi: 10.1002/adhm.201200193.
   PubMed Web of Science ®Google Scholar
• Bansal M, Dravid A, Aqrawe Z, et al. (2020). Conducting polymer hydrogels for electrically responsive drug delivery. J Control Release 328:192–209. doi: 10.1016/j.jconrel.2020.08.051.
   PubMed Web of Science ®Google Scholar
• Assa F, Jafarizadeh-Malmiri H, Ajamein H, et al. (2017). Chitosan magnetic nanoparticles for drug delivery systems. Crit Rev Biotechnol 37:492–509. doi: 10.1080/07388551.2016.1185389.
   PubMed Web of Science ®Google Scholar
• Liu Q, Tan Z, Zheng D, Qiu X. (2023). pH-responsive magnetic Fe(3)O(4)/carboxymethyl chitosan/aminated lignosulfonate nanoparticles with uniform size for targeted drug loading. Int J Biol Macromol 225:1182–92. doi: 10.1016/j.ijbiomac.2022.11.179.
   PubMed Web of Science ®Google Scholar
• Wang Z, Xue X, He Y, et al. (2018). Novel redox-responsive polymeric magnetosomes with tunable magnetic resonance property for in vivo drug release visualization and dual-modal cancer therapy. Adv Funct Mater 28:1802159. doi: 10.1002/adfm.201802159.
   Web of Science ®Google Scholar
• Jiang Z, Wang H, Zhang Z, et al. (2022). Cartilage targeting therapy with reactive oxygen species-responsive nanocarrier for osteoarthritis. J Nanobiotechnology 20:419. doi: 10.1186/s12951-022-01629-w.
   PubMed Web of Science ®Google Scholar
• Zhai Z, Ouyang W, Yao Y, et al. (2022). Dexamethasone-loaded ROS-responsive poly(thioketal) nanoparticles suppress inflammation and oxidative stress of acute lung injury. Bioact Mater 14:430–42. doi: 10.1016/j.bioactmat.2022.01.047.
   PubMed Web of Science ®Google Scholar
• Rinaldi A, Caraffi R, Grazioli MV, et al. (2022). Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines. Polymers (Basel) 14:687. doi: 10.3390/polym14040687.
   PubMed Web of Science ®Google Scholar
• Xiong MH, Bao Y, Yang XZ, et al. (2012). Lipase-sensitive polymeric triple-layered nanogel for “on-demand” drug delivery. J Am Chem Soc 134:4355–62. doi: 10.1021/ja211279u.
   PubMed Web of Science ®Google Scholar
• Vakili-Ghartavol R, Momtazi-Borojeni AA, Vakili-Ghartavol Z, et al. (2020). Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues. Artif Cells Nanomed Biotechnol 48:443–51. doi: 10.1080/21691401.2019.1709855.
   PubMed Web of Science ®Google Scholar
• Moore A, Marecos E, Bogdanov A, Jr., Weissleder R. (2000). Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568–74. doi: 10.1148/radiology.214.2.r00fe19568.
   PubMed Web of Science ®Google Scholar
• Jain TK, Reddy MK, Morales MA, et al. (2008). Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharmaceutics 5:316–27. doi: 10.1021/mp7001285.
   PubMed Web of Science ®Google Scholar
• Kessler A, Hedberg J, Blomberg E, Odnevall I. (2022). Reactive oxygen species formed by metal and metal oxide nanoparticles in physiological media-a review of reactions of importance to nanotoxicity and proposal for categorization. Nanomaterials 12:1922. doi: 10.3390/nano12111922.
   Web of Science ®Google Scholar
• Yu Z, Li Q, Wang J, et al. (2020). Reactive oxygen species-related nanoparticle toxicity in the biomedical field. Nanoscale Res Lett 15:115. doi: 10.1186/s11671-020-03344-7.
   PubMed Web of Science ®Google Scholar
• Jiang W, Kim BY, Rutka JT, Chan WC. (2008). Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–50. doi: 10.1038/nnano.2008.30.
   PubMed Web of Science ®Google Scholar
• Han J, Tian Y, Wang M, et al. (2022). Proteomics unite traditional toxicological assessment methods to evaluate the toxicity of iron oxide nanoparticles. Front Pharmacol 13:1011065. doi: 10.3389/fphar.2022.1011065.
   PubMed Web of Science ®Google Scholar
• Chrishtop VV, Mironov VA, Prilepskii AY, et al. (2021). Organ-specific toxicity of magnetic iron oxide-based nanoparticles. Nanotoxicology 15:167–204. doi: 10.1080/17435390.2020.1842934.
   PubMed Web of Science ®Google Scholar
• Panico S, Capolla S, Bozzer S, et al. (2022). Biological features of nanoparticles: protein corona formation and interaction with the immune system. Pharmaceutics 14:2605. doi: 10.3390/pharmaceutics14122605.
   PubMed Web of Science ®Google Scholar
• Kim W, Ly NK, He Y, et al. (2023). Protein corona: friend or foe? Co-opting serum proteins for nanoparticle delivery. Adv Drug Deliv Rev 192:114635. doi: 10.1016/j.addr.2022.114635.
   PubMed Web of Science ®Google Scholar
• Huang Z, Shen Y, Pei N, et al. (2013). The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation. Biomaterials 34:9905–16. doi: 10.1016/j.biomaterials.2013.08.092.
   PubMed Web of Science ®Google Scholar
• Morup S, Hansen MF, Frandsen C. (2010). Magnetic interactions between nanoparticles. Beilstein J Nanotechnol 1:182–90. doi: 10.3762/bjnano.1.22.
   PubMed Web of Science ®Google Scholar
• Champagne PO, Westwick H, Bouthillier A, Sawan M. (2018). Colloidal stability of superparamagnetic iron oxide nanoparticles in the central nervous system: a review. Nanomedicine 13:1385–400. doi: 10.2217/nnm-2018-0021.
   PubMed Web of Science ®Google Scholar
• Guerrini L, Alvarez-Puebla RA, Pazos-Perez N. (2018). Surface modifications of nanoparticles for stability in biological fluids. Materials 11:1154. doi: 10.3390/ma11071154.
   PubMed Web of Science ®Google Scholar
• Limongi T, Canta M, Racca L, et al. (2019). Improving dispersal of therapeutic nanoparticles in the human body. Nanomedicine (Lond) 14:797–801. doi: 10.2217/nnm-2019-0070.
   PubMed Web of Science ®Google Scholar
• Zhao D, Liu J, Wang M, et al. (2019). Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol 16:203–12. doi: 10.1038/s41569-018-0119-4.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Tong S, Zhang L, et al. (2017). Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions. Nat Commun 8:15594. doi: 10.1038/ncomms15594.
   PubMed Web of Science ®Google Scholar
• Hu J, Huang S, Zhu L, et al. (2018). Tissue plasminogen activator-porous magnetic microrods for targeted thrombolytic therapy after ischemic stroke. ACS Appl Mater Interfaces 10:32988–97. doi: 10.1021/acsami.8b09423.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang J, Huang S, et al. (2019). Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke. Biochem Biophys Res Commun 516:565–70. doi: 10.1016/j.bbrc.2019.06.079.
   PubMed Web of Science ®Google Scholar
• Choi W, Cho H, Kim G, et al. (2022). Targeted thrombolysis by magnetoacoustic particles in photothrombotic stroke model. Biomater Res 26:58. doi: 10.1186/s40824-022-00298-y.
   PubMedGoogle Scholar
• Li M, Li J, Chen J, et al. (2020). Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke. ACS Nano 14:2024–35. doi: 10.1021/acsnano.9b08587.
   PubMed Web of Science ®Google Scholar
• Kim HY, Kim TJ, Kang L, et al. (2020). Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials 243:119942. doi: 10.1016/j.biomaterials.2020.119942.
   PubMed Web of Science ®Google Scholar
• Zhang BF, Jiang H, Chen J, et al. (2019). Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction. J Cell Physiol 234:18544–59. doi: 10.1002/jcp.28492.
   PubMed Web of Science ®Google Scholar
• Lee JR, Park BW, Kim J, et al. (2020). Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair. Sci Adv 6:eaaz0952. doi: 10.1126/sciadv.aaz0952.
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang X, Wang J, et al. (2020). A peptide-functionalized magnetic nanoplatform-loaded melatonin for targeted amelioration of fibrosis in pressure overload-induced cardiac hypertrophy. Int J Nanomedicine 15:1321–33. doi: 10.2147/IJN.S235518.
   PubMed Web of Science ®Google Scholar
• Kiaie N, Emami SH, Rabbani S, et al. (2020). Targeted and controlled drug delivery to a rat model of heart failure through a magnetic nanocomposite. Ann Biomed Eng 48:709–21. doi: 10.1007/s10439-019-02394-y.
   PubMed Web of Science ®Google Scholar
• Naseroleslami M, Aboutaleb N, Parivar K. (2018). The effects of superparamagnetic iron oxide nanoparticles-labeled mesenchymal stem cells in the presence of a magnetic field on attenuation of injury after heart failure. Drug Deliv Transl Res 8:1214–25. doi: 10.1007/s13346-018-0567-8.
   PubMed Web of Science ®Google Scholar
• Yu L, Scherlag BS, Dormer K, et al. (2018). Targeted ganglionated plexi denervation using magnetic nanoparticles carrying calcium chloride payload. JACC Clin Electrophysiol 4:1347–58. doi: 10.1016/j.jacep.2018.06.012.
   PubMedGoogle Scholar
• Feigin VL, Stark BA, Johnson CO, et al. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol 20:795–820. doi: 10.1016/S1474-4422(21)00252-0.
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Sandset EC, et al. (2023). Thrombolysis for acute ischaemic stroke: current status and future perspectives. Lancet Neurol 22:418–29. doi: 10.1016/S1474-4422(22)00519-1.
   PubMed Web of Science ®Google Scholar
• Ma H, Jiang Z, Xu J, et al. (2021). Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke. Drug Deliv 28:357–71. doi: 10.1080/10717544.2021.1879315.
   PubMed Web of Science ®Google Scholar
• Grayston A, Zhang Y, Garcia-Gabilondo M, et al. (2022). Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke. J Cereb Blood Flow Metab 42:237–52. doi: 10.1177/0271678X211028816.
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang Y, Wang L, et al. (2021). Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment. Drug Deliv 28:380–9. doi: 10.1080/10717544.2021.1883158.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang J, Hao J, et al. (2021). Guiding drug through interrupted bloodstream for potentiated thrombolysis by C-shaped magnetic actuation system in vivo. Adv Mater 33:e2105351.
   PubMed Web of Science ®Google Scholar
• Chen HA, Ma YH, Hsu TY, Chen JP. (2020). Preparation of peptide and recombinant tissue plasminogen activator conjugated poly (Lactic-Co-Glycolic Acid) (PLGA) magnetic nanoparticles for dual targeted thrombolytic therapy. Int J Mol Sci 21:2690. doi: 10.3390/ijms21082690.
   PubMed Web of Science ®Google Scholar
• Xie M, Zhang W, Fan C, et al. (2020). Bioinspired soft microrobots with precise magneto-collective control for microvascular thrombolysis. Adv Mater 32:e2000366. doi: 10.1002/adma.202000366.
   PubMed Web of Science ®Google Scholar
• Pernal SP, Willis AJ, Sabo ME, et al. (2020). An in vitro model system for evaluating remote magnetic nanoparticle movement and fibrinolysis. Int J Nanomedicine 15:1549–68. doi: 10.2147/IJN.S237395.
   PubMed Web of Science ®Google Scholar
• Wang S, Guo X, Xiu W, et al. (2020). Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles. Sci Adv 6:eaaz8204. doi: 10.1126/sciadv.aaz8204.
   PubMed Web of Science ®Google Scholar
• Liu CH, Hsu HL, Chen JP, et al. (2019). Thrombolysis induced by intravenous administration of plasminogen activator in magnetoliposomes: dual targeting by magnetic and thermal manipulation. Nanomedicine 20:101992. doi: 10.1016/j.nano.2019.03.014.
   PubMed Web of Science ®Google Scholar
• Ouyang H, Zheng Z, Chen Y, et al. (2019). A magnetically modified black phosphorus nanosheet-based heparin delivery platform for preventing DVT accurately. J Mater Chem B 7:6099–108. doi: 10.1039/c9tb01459d.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Q, Wang W, et al. (2021). Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. J Neurol 268:4095–107. doi: 10.1007/s00415-020-10138-5.
   PubMed Web of Science ®Google Scholar
• Fischer UM, Harting MT, Jimenez F, et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18:683–92. doi: 10.1089/scd.2008.0253.
   PubMed Web of Science ®Google Scholar
• Khan H, Pan JJ, Li Y, et al. (2021). Native and bioengineered exosomes for ischemic stroke therapy. Front Cell Dev Biol 9:619565. doi: 10.3389/fcell.2021.619565.
   PubMed Web of Science ®Google Scholar
• Sun R, Wang X, Nie Y, et al. (2022). Targeted trapping of endogenous endothelial progenitor cells for myocardial ischemic injury repair through neutrophil-mediated SPIO nanoparticle-conjugated CD34 antibody delivery and imaging. Acta Biomater 146:421–33. doi: 10.1016/j.actbio.2022.05.003.
   PubMed Web of Science ®Google Scholar
• Bao S, Lu Y, Zhang J, et al. (2023). Rapid improvement of heart repair in rats after myocardial infarction by precise magnetic stimulation on the vagus nerve with an injectable magnetic hydrogel. Nanoscale 15:3532–41. doi: 10.1039/d2nr05073k.
   PubMed Web of Science ®Google Scholar
• Martin TG, Juarros MA, Leinwand LA. (2023). Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol 20:347–63. doi: 10.1038/s41569-022-00806-6.
   PubMed Web of Science ®Google Scholar
• Che H, Wang Y, Li H, et al. (2020). Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-beta1/Smads signaling in diabetic cardiomyopathy. Faseb J 34:5282–98. doi: 10.1096/fj.201902692R.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhuang T, Pi J, et al. (2019). Endothelial forkhead box transcription factor P1 regulates pathological cardiac remodeling through transforming growth factor-beta1-endothelin-1 signal pathway. Circulation 140:665–80. doi: 10.1161/CIRCULATIONAHA.119.039767.
   PubMed Web of Science ®Google Scholar
• Li H, Wang Y, Liu J, et al. (2021). Endothelial Klf2-Foxp1-TGFbeta signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling. Theranostics 11:1609–25. doi: 10.7150/thno.48153.
   PubMed Web of Science ®Google Scholar
• Roger VL. (2021). Epidemiology of heart failure: a contemporary perspective. Circ Res 128:1421–34. doi: 10.1161/CIRCRESAHA.121.318172.
   PubMed Web of Science ®Google Scholar
• Lazzarin T, Tonon CR, Martins D, et al. (2022). Post-cardiac arrest: mechanisms, management, and future perspectives. J Clin Med 12:259. doi: 10.3390/jcm12010259.
   PubMed Web of Science ®Google Scholar
• Xanthos T, Chatzigeorgiou M, Johnson EO, Chalkias A. (2012). Magnetically targeted drug delivery during cardiopulmonary resuscitation and the post-resuscitation period. Resuscitation 83:803–5. doi: 10.1016/j.resuscitation.2012.01.017.
   PubMedGoogle Scholar
• Wang W, Liu H, Lu Y, et al. (2019). Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia-reperfusion injury. Int J Nanomedicine 14:875–88. doi: 10.2147/IJN.S186225.
   PubMed Web of Science ®Google Scholar
• Sun X, Wang Y, Wen S, et al. (2021). Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest. J Nanobiotechnology 19:40. doi: 10.1186/s12951-021-00784-w.
   PubMed Web of Science ®Google Scholar
• Huang K, Wen S, Wang W, et al. (2021). Erythrocyte membrane coated nanoparticle-based control releasing hydrogen sulfide system protects ischemic myocardium. Nanomedicine (Lond) 16:465–80. doi: 10.2217/nnm-2020-0404.
   PubMed Web of Science ®Google Scholar
• Brundel B, Ai X, Hills MT, et al. (2022). Atrial fibrillation. Nat Rev Dis Primers 8:21. doi: 10.1038/s41572-022-00347-9.
   PubMed Web of Science ®Google Scholar